echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Why do well-known pharmaceutical companies spend nearly 100 million yuan to establish R & D bases in Hangzhou?

    Why do well-known pharmaceutical companies spend nearly 100 million yuan to establish R & D bases in Hangzhou?

    • Last Update: 2019-12-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [industry trends of pharmaceutical network] on December 9, Xianju pharmaceutical announced that it plans to increase the capital of its wholly-owned subsidiary Hangzhou Nengke love Medical Technology Co., Ltd (hereinafter referred to as "Nengke love") with its own capital of 93.95 million yuan, and invest in the construction of Xianju pharmaceutical Hangzhou R & D base in the existing Nengke love plot in Hangzhou According to the planning of Xianju pharmaceutical, the investment will be used to re plan and construct the 19 mu land under nenlovexin, making it a comprehensive R & D base with complete functions such as R & D supporting complex building and R & D building This base will mainly carry the R & D and operation of oral solid preparation, semi-solid preparation, injection R & D platform and inhalation R & D platform of Xianju pharmaceutical In addition, Xianju pharmaceutical also said that after the hardware foundation of Hangzhou R & D base is built, the project will create convenient conditions for attracting high-level R & D talents, which is conducive to the construction and upgrading of R & D platform If the project goes well, the possibility of continued investment is not ruled out It is worth noting that behind the action of the new R & D base, it can be clearly seen that Xianju pharmaceutical attaches great importance to high-end R & D talents In fact, in recent years, the enterprise's awareness of personnel training is rising It is reported that many well-known pharmaceutical enterprises, such as Fosun Pharmaceutical, have chosen to set up R & D institutions overseas in recent years, the purpose of which is to attract overseas local talents, so that they can also provide R & D support for pharmaceutical enterprises without leaving the country At present, in addition to the establishment of R & D centers and technology-based companies in talent gathering areas, many domestic pharmaceutical enterprises are attracting more professional talents through more competitive salary, personnel training and future development opportunities for new career, so as to form a stronger talent team and help the enterprise develop more steadily For example, before IPB In an interview with pharmaceutical.com, the sales engineer of an enterprise at Shanghai powder Expo 2019 revealed that in order to better provide EPC services for customers, the company has set up a technical company engaged in electrical software and control, which is specially located in Guangzhou for the convenience of talent pool, and in order to pool talents in mechanical design, it has set up a mechanical design company in Changsha The company that counts In addition, the company has always set up a perfect training mechanism The annual training cost of 1 million yuan has remained unchanged for many years This year, it has also set up a cadre training course specifically for employees Not only enterprises attach great importance to the cultivation of talents, but also Tianjin International Biomedical Joint Research Institute has established a "five school alliance of collaborative innovation" with five universities in Tianjin The alliance adopts a talent training mode of combination of production, teaching and research Through the alliance, university teachers who have made breakthroughs in drug research and development can come to the joint research institute to transform their achievements At the same time, the joint research institute also helps the settled enterprises to attract university graduate students to join the new drug R & D team, realize resource sharing among enterprises, universities and scientific research institutions, and help the cultivation of biomedical R & D talents In fact, the development of enterprises can not be separated from the support of talents Both R & D and sales need the participation of people But just because you invest in infrastructure doesn't mean there's a steady stream of talent What needs more optimization and reflection in the future is the investment awareness and strength of enterprises in R & D, as well as the efforts in recruitment, training, training and training of talent echelons  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.